Title : Successful treatment of sirolimus in a Chinese patient with refractory LN and APS: a case report.

Pub. Date : 2022

PMID : 35251323






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It has been reported that the mammalian target of rapamycin (mTOR) pathway is involved in the pathogenesis of systemic lupus erythematosus (SLE), and increasing evidence has shown the effect of mTOR-targeted therapies with sirolimus in SLE. Sirolimus mechanistic target of rapamycin kinase Homo sapiens
2 It has been reported that the mammalian target of rapamycin (mTOR) pathway is involved in the pathogenesis of systemic lupus erythematosus (SLE), and increasing evidence has shown the effect of mTOR-targeted therapies with sirolimus in SLE. Sirolimus mechanistic target of rapamycin kinase Homo sapiens
3 It has been reported that the mammalian target of rapamycin (mTOR) pathway is involved in the pathogenesis of systemic lupus erythematosus (SLE), and increasing evidence has shown the effect of mTOR-targeted therapies with sirolimus in SLE. Sirolimus mechanistic target of rapamycin kinase Homo sapiens
4 Treatment with the mTOR inhibitor sirolimus was initiated in this patient. Sirolimus mechanistic target of rapamycin kinase Homo sapiens